[go: up one dir, main page]

RU2020118380A - METHOD FOR PREVENTION OF HPV-ASSOCIATED CIN II-III AND CCR 1A1 ST - Google Patents

METHOD FOR PREVENTION OF HPV-ASSOCIATED CIN II-III AND CCR 1A1 ST Download PDF

Info

Publication number
RU2020118380A
RU2020118380A RU2020118380A RU2020118380A RU2020118380A RU 2020118380 A RU2020118380 A RU 2020118380A RU 2020118380 A RU2020118380 A RU 2020118380A RU 2020118380 A RU2020118380 A RU 2020118380A RU 2020118380 A RU2020118380 A RU 2020118380A
Authority
RU
Russia
Prior art keywords
surgitron
stage
cervical canal
cervical
electrode
Prior art date
Application number
RU2020118380A
Other languages
Russian (ru)
Other versions
RU2020118380A3 (en
RU2737051C2 (en
Inventor
Андрей Дмитриевич Каприн
Андрей Александрович Костин
Елена Григорьевна Новикова
Ольга Ивановна Трушина
Original Assignee
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) filed Critical Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России)
Priority to RU2020118380A priority Critical patent/RU2737051C2/en
Publication of RU2020118380A publication Critical patent/RU2020118380A/en
Publication of RU2020118380A3 publication Critical patent/RU2020118380A3/ru
Application granted granted Critical
Publication of RU2737051C2 publication Critical patent/RU2737051C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Plasma & Fusion (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)

Claims (1)

Способ профилактики ВПЧ-ассоциированных рецидивов СIN II-III и РШМ 1А1 СТ, включающий обследование и удаление шейки матки радиоволновым методом с использованием электрода-паруса аппарата Surgitron и петлевого электрода аппарата Surgitron диагностического кюретажа цервикального канала выше зоны резекции стенок цервикального канала, отличающийся тем, что осуществляют радиоволновое воздействие на ткани шейки матки поэтапно: I этап - выполняют радиоволновую конизацию шейки матки с использованием электрода-паруса аппарата Surgitron в режиме «Разрез и коагуляция» с мощностью 4-7 единиц с захватом средней и нижней трети цервикального канала с максимальным удалением патологических изменений предопухолевого и опухолевого характера; II этап - выполняют резекцию стенок цервикального канала с использованием петлевого электрода аппарата Surgitron в режиме «Разрез и коагуляция» с мощностью 4-7 единиц; III этап - выполняют кюретаж цервикального канала выше зоны резекции; IV этап - проводят вакцинацию тетравалентной вакциной против 6, 11, 16, 18-го типа по трехдозовой схеме подкожного введения 0-2-6 месяцев, после чего выполняют оценку противорецидивного и противовирусного эффектов вакцинации 1 раз в 3 месяца в течение первого года наблюдения и при отсутствии данных за рецидив заболевания, женщине разрешают планировать беременность. A method for the prevention of HPV-associated recurrences of CIN II-III and cervical cancer 1A1 CT, including examination and removal of the cervix by the radio wave method using a sail electrode of the Surgitron apparatus and a loop electrode of the Surgitron apparatus for diagnostic curettage of the cervical canal above the resection zone of the walls of the cervical canal, characterized in that carry out radio wave action on the cervical tissue in stages: Stage I - perform radio wave conization of the cervix using the sail electrode of the Surgitron apparatus in the "Incision and coagulation" mode with a power of 4-7 units with the capture of the middle and lower third of the cervical canal with the maximum removal of pathological changes precancerous and neoplastic nature; Stage II - resection of the walls of the cervical canal is performed using a loop electrode of the Surgitron apparatus in the "Incision and coagulation" mode with a capacity of 4-7 units; Stage III - curettage of the cervical canal is performed above the resection zone; Stage IV - vaccination is carried out with a tetravalent vaccine against type 6, 11, 16, 18 according to a three-dose scheme of subcutaneous administration for 0-2-6 months, after which the anti-relapse and antiviral effects of vaccination are assessed once every 3 months during the first year of observation and in the absence of data for a relapse of the disease, the woman is allowed to plan a pregnancy.
RU2020118380A 2020-06-04 2020-06-04 Method for prevention of hpv-associated recurrences of cin ii-iii and cc 1a1 st RU2737051C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2020118380A RU2737051C2 (en) 2020-06-04 2020-06-04 Method for prevention of hpv-associated recurrences of cin ii-iii and cc 1a1 st

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2020118380A RU2737051C2 (en) 2020-06-04 2020-06-04 Method for prevention of hpv-associated recurrences of cin ii-iii and cc 1a1 st

Publications (3)

Publication Number Publication Date
RU2020118380A true RU2020118380A (en) 2020-07-15
RU2020118380A3 RU2020118380A3 (en) 2020-10-28
RU2737051C2 RU2737051C2 (en) 2020-11-24

Family

ID=71617640

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020118380A RU2737051C2 (en) 2020-06-04 2020-06-04 Method for prevention of hpv-associated recurrences of cin ii-iii and cc 1a1 st

Country Status (1)

Country Link
RU (1) RU2737051C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2310197C1 (en) * 2006-03-17 2007-11-10 ФГУ Ростовский НИИ акушерства и педиатрии Росздрава Method for predicting pre-cancer diseases of uterine cervix in women with papilloma-viral infection
RU2379690C1 (en) * 2008-09-15 2010-01-20 Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "УрНИИДВиИ Росмедтехнологий") Diagnostic technique for papilloma virus infection
RU2394616C1 (en) * 2009-03-27 2010-07-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Федерального агентства по высокотехнологичной медицинской помощи" РФ Method of conservative treatment and relapse prevention of virus-associated precancer and early cancer of cervix
US8663964B2 (en) * 2011-07-20 2014-03-04 Tamir Biotechnology, Inc. Methods of treating human papillomavirus
RU2631411C1 (en) * 2016-08-24 2017-09-21 Общество с ограниченной ответственностью "ЭЛЛМАН-РУС" Method for treatment and diagnostic radio-surgical exposure of uterine cervix at suspected malignant damage and treatment tactics selection

Also Published As

Publication number Publication date
RU2020118380A3 (en) 2020-10-28
RU2737051C2 (en) 2020-11-24

Similar Documents

Publication Publication Date Title
Notaras Lateral subcutaneous sphincterotomy for anal fissure—a new technique
Rüdlinger et al. Human papillomavirus-35-positive bowenoid papulosis of the anogenital area and concurrent human papillomavirus-35-positive verruca with bowenoid dysplasia of the periungual area
Gerster On the surgical dissemination of cancer
CN108785656A (en) A kind of pharmaceutical preparation and preparation method thereof reducing cervical cancer pathogenesis risk
RU2020118380A (en) METHOD FOR PREVENTION OF HPV-ASSOCIATED CIN II-III AND CCR 1A1 ST
Ghoneim et al. Radical cystectomy for carcinoma of the bilharzial bladder
Jewett Jr Duplication of the entire small intestine with massive melena
Su et al. Laparoscopic para-aortic lymph node sampling in the staging of invasive cervical carcinoma: including a comparative study of 21 laparotomy cases
RU2150245C1 (en) Surgical method for treating generalized malignant tumors of external female genital organs
Wang et al. Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery for recurrent cervical high-grade squamous intraepithelial lesions following surgery
RU2631411C1 (en) Method for treatment and diagnostic radio-surgical exposure of uterine cervix at suspected malignant damage and treatment tactics selection
Kazandi et al. Evaluation of LOOP electrosurgical excisional procedure: case series
CN205514784U (en) Safe basket of supporting usefulness of ware is smashed to tissue
Stępień et al. Squamous Cell Carcinoma of perineal area developed from the Buschke-Löwenstein tumor
TOPEK Surgical treatment of carcinoma in situ of the cervix
Chen et al. A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: a non-randomized controlled prospective study
Mu et al. The Application of RENAL Nephrometry Score In Laparoscopic Partial Nephrectomy With Zero Ischemia And Sutureless
Mendagudli et al. CERVICAL CANCER-An Overview
Milanova et al. Operative treatment of cervical premalignant lesions and the presence of high-risk human papilloma virus as etiologic agent
Cherney CARCINOMA OF THE RECTUM—Low Abdominal Tranverse Incision for Resection with End-to-End Anastomosis
RU2197900C2 (en) Method for rectal resection by saving puborectal muscular ansa
Foppa Minimally invasive surgery in the treatment of gastrointestinal and endocrine tumors
Bakalianou et al. Advantages of radio frequency (RF) cone biopsy compared to large loop excision of the transformation zone (LLETZ) in patients with high-grade squamous intraepithelial lesions: a retrospective study
IMMUNISATION obtain material by aspiration punch biopsy with the
Beck et al. Anorectal neoplastic disorders